MentionFox
Home › IPO pipeline › Tang Capital Acquisition Corp.
IPO filings · Form S-1, F-1, 424B4, RW

Tang Capital Acquisition Corp. IPO

Before you invest in Tang Capital Acquisition Corp.

MentionFox check on Tang Capital Acquisition Corp.: only 2 sources on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/ipo/tang-capital-acquisition

Check Tang Capital Acquisition Corp. before you invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Tang Capital Acquisition Corp.?

Based on the records MentionFox holds for this company. No flag is not a clearance.

Tang Capital Acquisition Corp.'s initial public offering: every registration filing, amendment, final prospectus and withdrawal, with the facts quoted from the filings and each one linked.

Tang Capital Acquisition Corp. plans to list on the Nasdaq Capital Market under the symbol TCAA, offering 3,000,000 ordinary shares. It filed a Form S-1 registration statement for an initial public offering on October 6, 2026. As of November 4, 2026, its registration is amended and on file (Form S-1/A, October 16, 2026).

2 more IPO filings on the Nasdaq Capital Market, Q4 2026 ↓

Sell to companies like Tang Capital Acquisition Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

StatusAmended
TickerTCAA
ExchangeNasdaq Capital Market
First filed2026-10-06
Filings2

Tang Capital Acquisition Corp. filed a Form S-1 registration statement for an initial public offering on 2026-10-06. It has amended it 1 time. As of its latest filing, on 2026-10-16, it has not priced the offering or withdrawn it. Each fact below is quoted from the filing named with it.

What the filings say

Listing

We intend to apply to list our ordinary shares on The Nasdaq Capital Market, or Nasdaq, under the symbol "TCAA." We expect that our ordinary shares will begin trading on the date this prospectus becomes effective.From the S-1 filed 2026-10-06

Shares offered

We are offering 3,000,000 ordinary shares at a public offering price of $25.00 per share.From the S-1 filed 2026-10-06

Revenue

Global biopharmaceutical revenue was approximately $1.9 trillion in 2025 and has grown approximately 80% since 2015.From the S-1 filed 2026-10-06

Timeline

FiledWhat it isFiling
2026-10-06Registration statement filedS-1
2026-10-16Registration statement amendedS-1/A

Check before you invest in Tang Capital Acquisition Corp.: the warning signs and who's behind it, free.

Watch Tang Capital Acquisition Corp.: email me the next time it files something

Free to see. No signup.

Keep reading

More on Tang Capital Acquisition Corp. and the records around it.

Also filing to list on the Nasdaq Capital Market

IPO filings on the Nasdaq Capital Market in Q4 2026, newest first.

Want the whole picture on Tang Capital Acquisition Corp.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Tang Capital Acquisition Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Tang Capital Acquisition Corp. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Tools for this story

Each opens in a new tab, filled in for Tang Capital Acquisition Corp.. With no account yet, you sign up free and land on the result.

Where this comes from

A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.

Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/ipo/tang-capital-acquisition
Last updated 2026-11-04
Primary record: SEC filing 1 · SEC filing 2
Tang Capital Acquisition Corp. IPO (TCAA, Nasdaq Capital Market): registration amended. MentionFox, 2026-11-04. https://mentionfox.com/ipo/tang-capital-acquisition